Clinical Trial Update: Barley Protein and CVD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating barley protein for cardiovascular disease has completed, with results related to hypercholesterolemia and cardiovascular disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Hypercholesterolemia

Snippet

Sponsor: University of Toronto | Conditions: Hypercholesterolemia, Cardiovascular Disease | Phase 2 | Status: COMPLETED